Q2 2024 Holdings
Filed 2024-08-15 | 49 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $234.9M | 12,226,943 | 11.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $222.1M | 6,495,392 | 10.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $181.5M | 988,460 | 8.5% |
| Hillevax Inc | COM | 43157M102 | $153.5M | 10,617,062 | 7.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $104.1M | 10,109,279 | 4.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $97.4M | 2,371,304 | 4.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $92.0M | 3,632,604 | 4.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $81.7M | 8,785,284 | 3.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $79.1M | 1,754,834 | 3.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $78.5M | 1,039,405 | 3.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $67.2M | 3,731,067 | 3.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $54.3M | 2,165,591 | 2.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $47.9M | 3,314,349 | 2.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $43.4M | 3,687,867 | 2.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $43.1M | 1,587,527 | 2.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $38.7M | 997,455 | 1.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $38.3M | 16,216,216 | 1.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $37.6M | 871,974 | 1.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $35.7M | 875,667 | 1.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $33.6M | 1,561,230 | 1.6% |
| Savara Inc(SVRA) | COM | 805111101 | $32.9M | 8,157,385 | 1.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $29.3M | 4,142,855 | 1.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $24.3M | 770,000 | 1.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $24.0M | 1,502,788 | 1.1% |
| Merus N V | COM | N5749R100 | $22.1M | 373,100 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $22.0M | 7,381,090 | 1.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $21.8M | 1,148,591 | 1.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $17.5M | 425,000 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $16.1M | 4,623,324 | 0.8% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $16.1M | 393,000 | 0.8% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $15.8M | 4,401,371 | 0.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $13.4M | 1,152,456 | 0.6% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $13.3M | 832,220 | 0.6% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $12.8M | 3,010,727 | 0.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $10.7M | 2,286,135 | 0.5% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $10.0M | 3,062,558 | 0.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $8.0M | 1,000,000 | 0.4% |
| Elevation Oncology Inc | COM | 28623U101 | $8.0M | 2,958,579 | 0.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.9M | 936,576 | 0.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.6M | 470,338 | 0.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.6M | 285,331 | 0.4% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $7.3M | 1,069,244 | 0.3% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $6.7M | 2,867,750 | 0.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $4.5M | 2,088,889 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $4.4M | 500,333 | 0.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $4.0M | 1,195,179 | 0.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $3.7M | 108,762 | 0.2% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $1.0M | 245,692 | 0.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $290.8K | 264,377 | 0.0% |